Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade von Stroud, Chipman RG, Hegde, Aparna, Cherry, Cynthia, Naqash, Abdul R, Sharma, Nitika, Addepalli, Srikala, Cherukuri, Sulochana, Parent, Teresa, Hardin, Jessica, Walker, Paul

Volltext

Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune c... von Naqash, Abdul Rafeh, McCallen, Justin D, Mi, Emma, Iivanainen, Sanna, Marie, Mona A, Gramenitskaya, Daria, Clark, James, Koivunen, Jussi Pekka, Macherla, Shravanti, Jonnalagadda, Sweta, Polsani, Shanker, Jiwani, Rahim Ali, Hafiz, Maida, Muzaffar, Mahvish, Brunetti, Leonardo, Stroud, Chipman R G, Walker, Paul R, Wang, Kun, Chung, Youngmin, Ruppin, Eytan, Lee, Se-Hoon, Yang, Li V, Pinato, David J, Lee, Joo Sang, Cortellini, Alessio

Volltext